Arcturus Therapeutics

08/05/2026

We’re looking forward to attending SSIEM 2026 from August 25-28. Visit the Arcturus team at Booth S11 and learn more about our ongoing work in OTC deficiency and mRNA medicines.

08/04/2026

Thank you to the Cystic Fibrosis Research Institute for hosting another outstanding National CF Education Conference.

We were honored to join more than 450 attendees from 43 states and 19 countries (in person and virtually) who came together to learn, connect, and advance progress for the cystic fibrosis community.

If you missed the event, virtual recordings will be available soon.

Learn more about CFRI: cfri.org

Learn more about Arcturus' investigational mRNA program for cystic fibrosis: LUNAIRCF.com

07/23/2026

We're looking forward to attending the Cystic Fibrosis Research Institute's 39th National CF Education Conference starting tomorrow.

If you’re attending, we’d love to meet you. Please stop by the Arcturus table to connect with our team.

See you there!

07/16/2026

We’ll be at the National Urea Cycle Disorders Foundation Annual Family Conference starting tomorrow, July 17 through July 19. We look forward to connecting with attendees.

If you’re interested in learning more about Arcturus, we welcome you to stop by our table and say hello.

07/14/2026

07/09/2026

🌊 Stay connected, even on the go. Whether summer feels energizing or exhausting, CFRI’s Support Groups are here to offer grounding conversation and shared understanding. Register once and drop in throughout the year when you need support.

👉🏽 Register: https://www.cfri.org/education-support/psychosocial-support-programs/

CFRI support groups are made possible in 2026 to date by Viatris, Genentech, individual donors and bequests.

07/08/2026

Just two weeks until the 2026 NUCDF Family Conference!

In just two weeks, families, clinicians, researchers, industry partners, and advocates from across the UCD community will gather in Memphis for three days of learning, collaboration, and connection.

Over the next two weeks, we'll be taking our entire NUCDF community behind the scenes with a preview of this year's conference. We'll introduce each educational session and the remarkable speakers who are helping shape the future of UCD care, research, and advocacy.

Whether you'll be joining us in Memphis or following along from home, we invite you to count down with us as we celebrate the people, partnerships, and progress that make this community so special.

✨ Our Session Spotlight series begins July 5!

07/02/2026

⚠️ Did you know? OTC deficiency can cause dangerous ammonia buildup in the blood.

Early signs include vomiting, lethargy, confusion, and protein aversion.

Early detection can save lives.

Learn more about the signs of OTC deficiency in this resource from the National Urea Cycle Disorders Foundation: https://nucdf.org/about-ucd/recognize-the-signs/what-are-the-symptoms.html

Here are the symptoms of urea cycle disorders

06/30/2026

The CFTR protein acts like a microscopic gatekeeper, moving chloride out of cells to keep mucus thin and the lungs clear.

In cystic fibrosis, CFTR doesn’t work as it should — leading to thick mucus, infections, and breathing challenges.

Scientists are mapping CFTR in incredible detail to develop therapies that help it function.

Read more about CFTR from the Cystic Fibrosis Foundation: https://www.cff.org/research-clinical-trials/basics-cftr-protein

Cystic fibrosis occurs when the cystic fibrosis transmembrane conductance regulator (CFTR) protein is either not made correctly, or not made at all. By understanding how the protein is made, scientists have been able to develop treatments that target the protein and restore its function.